secwatch / observer
8-K filed June 26, 2023, 7:59 PM ET ticker AGL CIK 0001831097
other material confidence high sentiment neutral materiality 0.35

agilon health appoints Silvana Battaglia as independent director; three directors resign

agilon health, inc.

item 5.02item 8.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Clay Richards

Director
AGL · agilon health, inc.
Effective
2023-06-22
Successor
Silvana Battaglia
Filed
June 26, 2023, 7:59 PM ET
On June 21, 2023, each of Richard Schnall, Clay Richards and Derek L. Strum tendered letters of resignation from the Board of Directors (the “Board”) of agilon health, inc. (the “Company”), which resignations were effective on June 22, 2023.
Departed

Richard Schnall

Director
AGL · agilon health, inc.
Effective
2023-06-22
Filed
June 26, 2023, 7:59 PM ET
On June 21, 2023, each of Richard Schnall, Clay Richards and Derek L. Strum tendered letters of resignation from the Board of Directors (the “Board”) of agilon health, inc. (the “Company”), which resignations were effective on June 22, 2023.
Appointed

Silvana Battaglia

Director
AGL · agilon health, inc.
Effective
2023-06-22
Filed
June 26, 2023, 7:59 PM ET
On June 22, 2023, the Board, upon the recommendation of the Nominating and Governance Committee, appointed Silvana Battaglia as an independent Class I Director in accordance with the Company’s Amended and Restated Certificate of Incorporation, to fill the vacancy on the Board created by Mr. Richard’s resignation from the Board.
Departed

Derek L. Strum

Director
AGL · agilon health, inc.
Effective
2023-06-22
Filed
June 26, 2023, 7:59 PM ET
On June 21, 2023, each of Richard Schnall, Clay Richards and Derek L. Strum tendered letters of resignation from the Board of Directors (the “Board”) of agilon health, inc. (the “Company”), which resignations were effective on June 22, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Clay Richards resigned as Director at agilon health, inc..

Action
resigned
Role
Director
Exact text from the filing
On June 21, 2023, each of Richard Schnall, Clay Richards and Derek L. Strum tendered letters of resignation from the Board of Directors (the “Board”) of agilon health, inc. (the “Company”), which resignations were effective on June 22, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Schnall resigned as Director at agilon health, inc..

Action
resigned
Role
Director
Exact text from the filing
On June 21, 2023, each of Richard Schnall, Clay Richards and Derek L. Strum tendered letters of resignation from the Board of Directors (the “Board”) of agilon health, inc. (the “Company”), which resignations were effective on June 22, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Silvana Battaglia was appointed as Director at agilon health, inc..

Action
appointed
Role
Director
Exact text from the filing
On June 22, 2023, the Board, upon the recommendation of the Nominating and Governance Committee, appointed Silvana Battaglia as an independent Class I Director in accordance with the Company’s Amended and Restated Certificate of Incorporation, to fill the vacancy on the Board created by Mr. Richard’s resignation from the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Derek L. Strum resigned as Director at agilon health, inc..

Action
resigned
Role
Director
Exact text from the filing
On June 21, 2023, each of Richard Schnall, Clay Richards and Derek L. Strum tendered letters of resignation from the Board of Directors (the “Board”) of agilon health, inc. (the “Company”), which resignations were effective on June 22, 2023.
View on SEC.gov

agilon health, inc. filing history →

Source: SEC EDGAR
accession 0001019056-23-000285
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.